Thomas Schlange

4.0k citations

32 papers · 2.7k indexed · 1 hit paper · h-index 21

Impact in

Statistics, Probability and Uncertainty top 1%
- Meta-analysis and systematic reviews
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Cancer Research 10
- Cancer Genomics and Diagnostics 7
- Cancer-related molecular mechanisms research 3
Immunology and Allergy 3

Co-authors: Florian Prinz Khusru Asadullah Nancy E. Hynes Thomas Brand Hans-Henning Arnold Thomas Krahn Yutaka Matsuda Birgit Andrée
Journals: Cancer Research (3 papers)Breast Cancer Research (2 papers)Mechanisms of Development (2 papers)Cancers (2 papers)Clinical Chemistry (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Thomas Schlange

30 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Believe it or not: how much can we rely on published data on potential drug targets? 2011 · 1.1k citations

Peers

Countries citing papers authored by Thomas Schlange

Since Specialization

Citations

This map shows the geographic impact of Thomas Schlange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schlange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schlange more than expected).

Fields of papers citing papers by Thomas Schlange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schlange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schlange. The network helps show where Thomas Schlange may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Schlange, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Schlange Line = papers co-authored together Thomas Schlange links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy Lung ·L. Gratton, Stefan Bentink, Christian Heßlinger, Thomas B. Leonard, Megan L. Neely, Nina Patel, Thomas Schlange, Jamie L. Todd, Richard Vinisko, Margaret L. Salisbury, (unknown)	2024	1
2	Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors JCO Precision Oncology ·Sabrina Weber, Paul van der Leest, Cicih Widianingsih, Thomas Schlange, Wim Timens, Menno Tamminga, 紘毅高島, Ricarda Graf, Tina Moser, 水野勉, Marie‐Laure Yaspo, Leon W.M.M. Terstappen, Grigory Sidorenkov, T. Jeroen N. Hiltermann, Michael R. Speicher, Ed Schuuring, Ellen Heitzer, Harry J.M. Groen	2021	45
3	International liquid biopsy standardization alliance white paper Critical Reviews in Oncology/Hematology ·Dana E. Connors, Jeff Allen, Ha-Hieu Pham, Jennifer Boyle, Massimo Cristofanilli, Jill M Oglesbee, Susan M. Keating, Edelcio Jacomassi, タンナーグェンティ, Robert McCormack, Diana M. Merino, 彰夫笠原, Klaus Pantel, Christian Rolfo, María José Serrano, Janine Rupec, Thomas Schlange, Caroline C. Sigman, Mark Stewart	2020	70
4	Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? Molecular Aspects of Medicine ·Rita Lampignano, Vera Kloten, Thomas Krahn, Thomas Schlange	2020	23
5	The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS Respiratory Research ·(unknown), J. Michael Wells, Dongqi Xing, Liliana Viera, مجد إبراهيم محمد الوهبة الكلوب, Jyh-Honrg Chen, Surya P. Bhatt, Mark T. Dransfield, David Couper, Wanda K. O’Neal, Eric A. Hoffman, Amit Gaggar, Igor Barjaktarević, Jeffrey L. Curtis, Wassim W. Labaki, Mei Han, Christine M. Freeman, Nirupama Putcha, Thomas Schlange, J. Edwin Blalock	2019	7
6	Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows Clinical Chemistry ·Vera Kloten, Martin H. Neumann, Francesca Di Pasquale, Markus Sprenger‐Haussels, Jonathan M. Shaffer, Martin Schlumpberger, Andrei Herdean, Fay Betsou, Wim Ammerlaan, Mish Loraine, Sayati Mandia, Gotthard Günther, Evi Lianidou, Robert Sjöback, Mikael Kubista, Sebastian Bender, Rita Lampignano, Thomas Krahn, Thomas Schlange	2019	41
7	ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress Computational and Structural Biotechnology Journal ·Martin H. Neumann, Sebastian Bender, Thomas Krahn, Thomas Schlange	2018	165
8	Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas British Journal of Cancer ·A. V. Salnikov, Niko P. Bretz, Claudia Perne, John Hazin, Sandro Keller, Mina Fogel, Ingrid Herr, Thomas Schlange, Gerhard Moldenhauer, Peter Altevogt	2013	64
9	CD24 controls Src/STAT3 activity in human tumors Cellular and Molecular Life Sciences ·Niko P. Bretz, Alexei V. Salnikov, Claudia Perne, Sascha Keller, Xiaoli Wang, Claudia Tanja Mierke, Mina Fogel, H.A.M. Meeuwsen, Thomas Schlange, Gerhard Moldenhauer, Peter Altevogt	2012	71
10	WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth Breast Cancer Research ·Yutaka Matsuda, Thomas Schlange, Edward J. Oakeley, Anne Boulay, Nancy E. Hynes	2009	128
11	Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways Biochemical and Biophysical Research Communications ·Ivana Samaržija, Patrizia Sini, Thomas Schlange, Gwen MacDonald, Nancy E. Hynes	2009	57
12	Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation Breast Cancer Research ·Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E. Hynes	2007	176
13	Targeting ADAMS and ERBBs in lung cancer Cancer Cell ·Nancy E. Hynes, Thomas Schlange	2006	36
14	Novel c‐MYC target genes mediate differential effects on cell proliferation and migration EMBO Reports ·David Cappellen, Thomas Schlange, Jean Paul Rokotovao, Francisca Maurer, Nancy E. Hynes	2006	82
15	Effects of antisense misexpression of CFC on downstream flectin protein expression during heart looping Developmental Dynamics ·Kérsti K. Linask, Mingda Han, Kaari L. Linask, Thomas Schlange, Thomas Brand	2003	30
16	BMP2 is a positive regulator of Nodal signaling during left-right axis formation in the chicken embryo Development ·Thomas Schlange, Hans-Henning Arnold, Thomas Brand	2002	58
17	Chick CFC Controls Lefty1 Expression in the Embryonic Midline and Nodal Expression in the Lateral Plate Developmental Biology ·Thomas Schlange, Julieta G. García‐Donas, Birgit Andrée, Andreas D. Ebert, Michael R. Zile, Hans-Henning Arnold, Thomas Brand	2001	35
18	BMP2 is required for early heart development during a distinct time period Mechanisms of Development ·Thomas Schlange, Birgit Andrée, Hans-Henning Arnold, Thomas Brand	2000	160
19	Expression analysis of the chicken homologue of CITED2 during early stages of embryonic development Mechanisms of Development ·Thomas Schlange, Birgit Andrée, Hans-Henning Arnold, Thomas Brand	2000	20
20	The homeobox gene it NKX3.2 is a target of left–right signalling and is expressed on opposite sides in chick and mouse embryos Current Biology ·André Schneider, Chaoxin Ji, Thomas Schlange, D. Willebrands, Paul A. Overbeek, Hans-Henning Arnold, Thomas Brand	1999	79

About Thomas Schlange

Thomas Schlange is a scholar working on Cancer Research, Immunology and Allergy, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 2.7k indexed citations. Recurring topics across this work include Congenital heart defects research (7 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Cells and Metastasis (5 papers), Developmental Biology and Gene Regulation (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer-related molecular mechanisms research (3 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Statistics, Probability and Uncertainty (272 citations), Cancer Research (492 citations), Small Animals (179 citations), Molecular Biology (1.4k citations) and Oncology (536 citations). Thomas Schlange has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Florian Prinz, Khusru Asadullah, Nancy E. Hynes, Thomas Brand, Hans-Henning Arnold, Thomas Krahn, Yutaka Matsuda, Birgit Andrée, Sebastian Bender and Martin H. Neumann. Their work appears in journals such as Cancer Research, Breast Cancer Research, Mechanisms of Development, Cancers and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact